Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease

Background: Reduction of serum LDL-cholesterol by statins was shown to improve clinical outcomes in patients with coronary heart disease (CHD). Although intensive statin therapy significantly reduced cardiovascular risks, atherosclerotic cardiovascular events have not been completely prevented. Ther...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Atheroscler Thromb
Main Authors: Yamashita, Shizuya, Masuda, Daisaku, Ohama, Tohru, Arai, Hidenori, Bujo, Hideaki, Kagimura, Tatsuo, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji
פורמט: Artigo
שפה:Inglês
יצא לאור: Japan Atherosclerosis Society 2016
נושאים:
Study Profile
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399286/
https://ncbi.nlm.nih.gov/pubmed/26803913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.32813
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים